Published by Josh White on 23rd September 2024
(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.
URL: http://www.digitallook.com/dl/news/story/34572535/...